Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
In this episode, Yu-Wen Hsiao, Marketing and Communications Manager, APAC at Criticaleye, speaks with Ray Ferguson, Global Board Chair and seasoned international banker, shares his perspective on how CEOs and Boards ...
Donal Murphy, CEO of DCC plc, has led a large-scale transformation over the last 18 months. He talks to Criticaleye's Marc Barber about why the company's future lies in energy As a young man...
BLOG | A Long-term View of the Business Landscape
Last week, we hosted a Leadership in the Boardroom Dinner: A Long-term View of the Business Landscape, bringing together Board members and senior executives to discuss the economic, technological and geopolitical for...
Displaying 1 to 3 of 186
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
